Anna Lato
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anna Lato has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Grażyna Wyszyńska-Pawelec
Department of Cranio-Maxillofacial Surgery, Jagiellonian University Medical College, 30-688 Cracow, Poland
2 shared publications - Jakub Bargiel
Department of Cranio-Maxillofacial Surgery, Jagiellonian University Medical College, 30-688 Cracow, Poland
2 shared publications - Julia Miaśkiewicz
Students’ Scientific Group, Department of Cranio-Maxillofacial Surgery, Jagiellonian University Medical College, 31-501 Krakow, Poland
2 shared publications - Krzysztof Gąsiorowski
Department of Cranio-Maxillofacial Surgery, Jagiellonian University Medical College, 30-688 Cracow, Poland
2 shared publications - Michał Gontarz
Department of Cranio-Maxillofacial Surgery, Jagiellonian University Medical College, Jakubowskiego 2 Street, 30-688 Cracow, Poland
2 shared publications - Tomasz Marecik
Department of Cranio-Maxillofacial Surgery, Jagiellonian University Medical College, 30-688 Cracow, Poland
2 shared publications
Latest Publications
- Open Access
- 6 October 2026
- Published by Taylor & Francis in Acta Oto-Laryngologica Case Reports
- Vol. 11 (1) , 220-227
Orbital metastasis from thigh myxoid/round cell liposarcoma: a rare case report
1. Myxoid/round cell liposarcoma (MRCLS), currently classified as high-grade myxoid liposarcoma (MLS), is a major subtype of soft tissue sarcoma in adults, commonly affecting the extremities, parti...
- 6 October 2026
- Published by Taylor & Francis in Acta Oto-Laryngologica Case Reports
- Vol. 11 (1) , 220-227
Open AccessOrbital metastasis from thigh myxoid/round cell liposarcoma: a rare case report
1. Myxoid/round cell liposarcoma (MRCLS), currently classified as high-grade myxoid liposarcoma (MLS), is a major subtype of soft tissue sarcoma in adults, commonly affecting the extremities, parti...
- Open Access
- 1 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (1) , 331
Site- and Size-Based Algorithm for Reconstruction of Cheek Skin Defects: A Single-Center Retrospective Study
Background: The rising incidence of cutaneous non-melanoma skin cancers underscores the need for individualized reconstruction, particularly for cheek defects that pose distinctive anatomic and functional challenges. This study aimed to analyze reconstructive patterns for cheek skin lesions and to develop a simple, site- and size-based algorithm for small- to medium-sized defects. Methods: We retrospectively reviewed 129 consecutive patients treated between 2022 and 2025 for primary basal cell carcinoma, squamous cell carcinoma, or benign cheek skin tumors. After excision, defects were reconstructed with primary closure, local flaps, or skin grafts. Associations between the largest clinically measured lesion diameter (used as a proxy for the post-excision defect size), anatomical subsite, histopathology, and reconstructive technique were evaluated using ANOVA or Kruskal–Wallis tests, chi-square tests, and Spearman’s correlation. Results: The mean lesion diameter was 19.75 ± 12.93 mm. Reconstruction was performed using local flaps in 62 patients (48.06%), primary closure in 53 (41.09%), and skin grafts in 14 (10.85%). Larger defects were more frequently managed with grafts or flaps (F(2,110) = 4.84, p = 0.010), and lesion size correlated with reconstructive complexity (Spearman’s ρ = 0.229, p = 0.015). Lesion location was also significantly associated with the reconstruction method (χ2(10) = 48.29, p < 0.001; Cramér’s V = 0.44). Margin-negative (R0) excision was achieved in 95.35% of cases, with a low recurrence rate (3.91%) and complication rate (1.56%). Conclusions: Lesion size and anatomical location are key determinants of reconstructive strategy for cheek skin defects. In this cohort, lesions ≤ 20 mm were predominantly managed with primary closure, whereas lesions > 20 mm more frequently required flap reconstruction or skin grafting. This size-based split is cohort-derived and should be interpreted as a pragmatic framework that requires external validation.
- 1 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (1) , 331
Open AccessSite- and Size-Based Algorithm for Reconstruction of Cheek Skin Defects: A Single-Center Retrospective Study
Background: The rising incidence of cutaneous non-melanoma skin cancers underscores the need for individualized reconstruction, particularly for cheek defects that pose distinctive anatomic and functional challenges. This study aimed to analyze reconstructive patterns for cheek skin lesions and to develop a simple, site- and size-based algorithm for small- to medium-sized defects. Methods: We retrospectively reviewed 129 consecutive patients treated between 2022 and 2025 for primary basal cell carcinoma, squamous cell carcinoma, or benign cheek skin tumors. After excision, defects were reconstructed with primary closure, local flaps, or skin grafts. Associations between the largest clinically measured lesion diameter (used as a proxy for the post-excision defect size), anatomical subsite, histopathology, and reconstructive technique were evaluated using ANOVA or Kruskal–Wallis tests, chi-square tests, and Spearman’s correlation. Results: The mean lesion diameter was 19.75 ± 12.93 mm. Reconstruction was performed using local flaps in 62 patients (48.06%), primary closure in 53 (41.09%), and skin grafts in 14 (10.85%). Larger defects were more frequently managed with grafts or flaps (F(2,110) = 4.84, p = 0.010), and lesion size correlated with reconstructive complexity (Spearman’s ρ = 0.229, p = 0.015). Lesion location was also significantly associated with the reconstruction method (χ2(10) = 48.29, p < 0.001; Cramér’s V = 0.44). Margin-negative (R0) excision was achieved in 95.35% of cases, with a low recurrence rate (3.91%) and complication rate (1.56%). Conclusions: Lesion size and anatomical location are key determinants of reconstructive strategy for cheek skin defects. In this cohort, lesions ≤ 20 mm were predominantly managed with primary closure, whereas lesions > 20 mm more frequently required flap reconstruction or skin grafting. This size-based split is cohort-derived and should be interpreted as a pragmatic framework that requires external validation.
- Open Access
- 11 July 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (14) , 4931
Surgical Treatment of Mandibular Coronoid Process Hypertrophy Syndrome
Background/Objectives: Mandibular coronoid process hypertrophy (MCPH) is a rare condition characterized by an abnormal enlargement of the mandibular coronoid process, resulting in restricted mouth opening and reduced lateral mandibular movements due to interference with the zygomatic bone. The objective of this paper is to evaluate the functional outcomes of intraoral coronoidectomy followed by physiotherapy in five consecutive patients with MCPH. Methods: Five male patients (mean age 38 ± 18.7 years) with radiologically confirmed bilateral MCPH underwent intraoral coronoidectomy between May 2020 and December 2022. Maximal inter-incisal opening (MIO) was measured pre-operatively, on postoperative day 1, and at 6-month follow-up. A standardized 5-10-60 mouth-opening exercise protocol using a Heister mouth gag was administered from postoperative day 1. Results: The hyperplastic mandibular coronoid processes were removed intraorally without any long-lasting complications. All patients demonstrated a postoperative increase in mouth opening. Notably, patients with more severe mouth-opening limitations showed greater improvement compared with those with milder initial restrictions. Conclusions: Intraoral coronoidectomy, combined with early and intensive physiotherapy, represents a safe and effective treatment for MCPH. Early diagnosis and timely surgical intervention are crucial to prevent ineffective non-surgical management. Additionally, a modest initial postoperative increase in mouth opening should not be considered the final outcome, as these patients often achieve substantial long-term functional improvement.
- 11 July 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (14) , 4931
Open AccessSurgical Treatment of Mandibular Coronoid Process Hypertrophy Syndrome
Background/Objectives: Mandibular coronoid process hypertrophy (MCPH) is a rare condition characterized by an abnormal enlargement of the mandibular coronoid process, resulting in restricted mouth opening and reduced lateral mandibular movements due to interference with the zygomatic bone. The objective of this paper is to evaluate the functional outcomes of intraoral coronoidectomy followed by physiotherapy in five consecutive patients with MCPH. Methods: Five male patients (mean age 38 ± 18.7 years) with radiologically confirmed bilateral MCPH underwent intraoral coronoidectomy between May 2020 and December 2022. Maximal inter-incisal opening (MIO) was measured pre-operatively, on postoperative day 1, and at 6-month follow-up. A standardized 5-10-60 mouth-opening exercise protocol using a Heister mouth gag was administered from postoperative day 1. Results: The hyperplastic mandibular coronoid processes were removed intraorally without any long-lasting complications. All patients demonstrated a postoperative increase in mouth opening. Notably, patients with more severe mouth-opening limitations showed greater improvement compared with those with milder initial restrictions. Conclusions: Intraoral coronoidectomy, combined with early and intensive physiotherapy, represents a safe and effective treatment for MCPH. Early diagnosis and timely surgical intervention are crucial to prevent ineffective non-surgical management. Additionally, a modest initial postoperative increase in mouth opening should not be considered the final outcome, as these patients often achieve substantial long-term functional improvement.